A phase 2 liver trial where the add-on drug didn't help — and the base drug quietly did
Read the Sunday Brief →

Study wrapper · #999

Efficacy and Safety of Glutathione Supplementation in Patients with HIV Infection and HIV-Tuberculosis Co-Infection.

Dawi J, Affa S, Au S, et al. Nutrients. 2026.
MixedReviewMentions: Glutathione

Editor's note

A narrative review with glutathione as its central subject in HIV and HIV-TB co-infection. It reports consistent safety and associations with restored thiol balance and immune function, while noting short study durations and lack of standardized biomarkers. Encouraging but not practice-changing.

Plain-language abstract

This review examines glutathione supplementation and precursor strategies in HIV and HIV-tuberculosis co-infection, reporting associations with improved immune and mitochondrial function.